We serve Chemical Name:tert-butyl 6-nitroindazole-1-carboxylate CAS:219503-74-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:tert-butyl 6-nitroindazole-1-carboxylate
CAS.NO:219503-74-9
Synonyms:tert-Butyl 6-nitro-1H-indazole-1-carboxylate;1-Boc-6-nitroindazole
Molecular Formula:C12H13N3O4
Molecular Weight:263.24900
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:406.066ºC at 760 mmHg
Density:1.342g/cm3
Index of Refraction:1.606
PSA:89.94000
Exact Mass:263.09100
LogP:3.25090
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like tert-Butyl 6-nitro-1H-indazole-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Boc-6-nitroindazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-Butyl 6-nitro-1H-indazole-1-carboxylate Use and application,tert-Butyl 6-nitro-1H-indazole-1-carboxylate technical grade,usp/ep/jp grade.
Related News: British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights. tert-butyl 6-nitroindazole-1-carboxylate manufacturer The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth. tert-butyl 6-nitroindazole-1-carboxylate supplier In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials. tert-butyl 6-nitroindazole-1-carboxylate vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. tert-butyl 6-nitroindazole-1-carboxylate factory The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.
